CEA AND HMFG IN HYPERPLASTIC AND MALIGNANT LESIONS OF THE BREAST

被引：14

作者：

DEPOTTER, CR ^{[1
]}

BEGHIN, C ^{[1
]}

PRAET, MM ^{[1
]}

PAUWELS, CF ^{[1
]}

ROELS, HJ ^{[1
]}

机构：

[1] STATE UNIV GHENT HOSP,DEPT PATHOL,B-9000 GHENT,BELGIUM

来源：

PATHOLOGY RESEARCH AND PRACTICE | 1988年 / 183卷 / 03期

关键词：

D O I：

10.1016/S0344-0338(88)80121-3

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：271 / 276

页数：6

共 36 条

[1]

AHNEN DJ, 1982, CANCER, V49, P2077, DOI 10.1002/1097-0142(19820515)49:10<2077::AID-CNCR2820491020>3.0.CO

[2]

2-X

[3]

[Anonymous], 1986, Arch Pathol Lab Med, V110, P171

[4]

AZZOPARDI JG, 1979, PROBLEMS BREAST PATH, P128

[5] CORRELATION OF IMMUNOHISTOCHEMICAL MARKERS WITH PATIENT PROGNOSIS IN BREAST-CARCINOMA - A QUANTITATIVE STUDY [J].

BARRY, JD ;

KOCH, TJ ;

COHEN, C ;

BRIGATI, DJ ;

SHARKEY, FE .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 82 (05) :582-585

[6] THE PROGNOSTIC VALUE OF THE MONOCLONAL-ANTIBODIES HMFG1 AND HMFG2 IN BREAST-CANCER [J].

BERRY, N ;

JONES, DB ;

SMALLWOOD, J ;

TAYLOR, I ;

KIRKHAM, N ;

TAYLORPAPADIMITRIOU, J .

BRITISH JOURNAL OF CANCER, 1985, 51 (02) :179-186

[7] HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].

BLOOM, HJG ;

RICHARDSON, WW .

BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&

[8]

DEPOTTER CR, 1986, 4TH INT C SEN PAR

[9] RISK-FACTORS FOR BREAST-CANCER IN WOMEN WITH PROLIFERATIVE BREAST DISEASE [J].

DUPONT, WD ;

PAGE, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) :146-151

[10]

FLEISHER M, 1974, CLIN CHEM, V20, P41

← 1 2 3 4 →